Stocksigma LogoStocksigma Logo

Jagsonpal Pharmaceuticals to Acquire Group Pharma’s Wellness Portfolio for up to ₹46.7 Crores

Jagsonpal Pharmaceuticals signed a Business Transfer Agreement on 23rd Sep'26 to acquire the Wellness Portfolio of Group Pharmaceuticals via a slump sale

Jagsonpal Pharmaceuticals to Acquire Group Pharma’s Wellness Portfolio for up to ₹46.7 Crores

Jagsonpal Pharmaceuticals Ltd · Others (Uncategorized) · 23 Sept 2026, 11:22 pm

Jagsonpal Pharmaceuticals to Acquire Group Pharma’s Wellness Portfolio for up to ₹46.7 Crores Jagsonpal Pharmaceuticals signed a Business Transfer Agreement on 23rd Sep'26 to acquire the Wellness Portfolio of Group Pharmaceuticals via a slump sale on a going-concern basis. The target portfolio generated ₹24.6 crore in FY26 turnover. Total consideration is capped at ₹46.7 crore, comprising an upfront cash payment of ₹23.7 crore at closing and up to ₹23.0 crore in performance-linked earnouts tied to FY28 sales. The deal expands Jagsonpal’s footprint in women’s healthcare and is expected to close on or before 1st Nov'26.

Original exchange filing (PDF)

More announcements from Jagsonpal Pharmaceuticals Ltd

All Jagsonpal Pharmaceuticals Ltd announcements